DEBORAH IBARRA: Open Payments
NPI 1407359946 · DORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,778 in 118 payments from 15 companies in 2025. Trend: 2023 $939 · 2024 $2,253 · 2025 $2,778
Food & beverage: $2,778
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 24 | $603 |
| Janssen Pharmaceuticals, Inc | 10 | $351 |
| Axsome Therapeutics, Inc. | 15 | $350 |
| ABBVIE INC. | 16 | $308 |
| Vanda Pharmaceuticals Inc. | 9 | $236 |
| Otsuka America Pharmaceutical, Inc. | 11 | $211 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $205 |
| Alkermes, Inc. | 6 | $124 |
| E.R. Squibb & Sons, L.L.C. | 5 | $122 |
| Collegium Pharmaceutical, Inc. | 5 | $103 |
Products named: Azstarys, SPRAVATO, Auvelity, VRAYLAR, REXULTI, CAPLYTA, ARISTADA, FANAPT.
Industry payments across FL — which companies pay providers there.
